C. Bourgier

发表

Breast elasticity: principles, technique, results: an update and overview of commercially available software.

M. Mathieu, C. Balleyguier, C. Dromain, 2013, European journal of radiology.

T lymphocytes to predict radiation-induced late effects in normal tissues

C. Bourgier, M. Brengues, A. Pèlegrin, 2017, Expert review of molecular diagnostics.

Radio-induced cardiotoxicity: From physiopathology and risk factors to adaptation of radiotherapy treatment planning and recommended cardiac follow-up.

M. Aznar, C. Bourgier, Y. Kirova, 2020, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Late side-effects after curative intent radiotherapy: Identification of hypersensitive patients for personalized strategy.

J. Solassol, A. Mangé, M. Ozsahin, 2015, Critical reviews in oncology/hematology.

Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial☆

Sébastien Clippe, Christophe Hennequin, André Pèlegrin, 2015, EBioMedicine.

Improving Patients’ Life Quality after Radiotherapy Treatment by Predicting Late Toxicities

M. Ozsahin, C. Bourgier, M. Brengues, 2022, Cancers.

Quantitative proteomic analysis reveals AK2 as potential biomarker for late normal tissue radiotoxicity

J. Solassol, A. Mangé, M. Ozsahin, 2019, Radiation Oncology.

Multi-centre technical evaluation of the radiation-induced lymphocyte apoptosis assay as a predictive test for radiotherapy toxicity

J. Chang-Claude, F. Wenz, C. West, 2019, Clinical and translational radiation oncology.

REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer.

J. Chang-Claude, T. Vercauteren, A. Dunning, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

In Regard to Pereira et al.

M. Ozsahin, C. Bourgier, M. Brengues, 2018, International journal of radiation oncology, biology, physics.

Impact of adjuvant hormonotherapy on radiation-induced breast fibrosis according to the individual radiosensitivity: results of a multicenter prospective French trial

C. Bourgier, C. Hennequin, F. Mornex, 2018, Oncotarget.

One Size Fits All: Does the Dogma Stand in Radiation Oncology?

C. Bourgier, M. Brengues, D. Azria, 2016, EBioMedicine.

Concurrent or sequential letrozole with adjuvant breast radiotherapy: primetime for personalized radiation oncology

C. Bourgier, D. Azria, 2016 .

Identifying patients at risk for late radiation-induced toxicity.

M. Ozsahin, C. Bourgier, D. Azria, 2012, Critical reviews in oncology/hematology.

An auristatin‐based antibody‐drug conjugate targeting HER3 enhances the radiation response in pancreatic cancer

P. Colombo, N. Radosevic-Robin, C. Theillet, 2019, International journal of cancer.

Radiation therapy and immunotherapy: implications for a combined cancer treatment.

Cyrus Chargari, E. Deutsch, C. Bourgier, 2013, Critical reviews in oncology/hematology.

3D-conformal Accelerated Partial Breast Irradiation treatment planning: the value of surgical clips in the delineation of the lumpectomy cavity

A. Dunant, H. Marsiglia, M. Spielmann, 2009, Radiation oncology.

Enhanced local control by radiation boost in breast cancer: back side of the coin?

R. Arriagada, C. Bourgier, M. Vozenin-Brotons, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Five-year results of the Preoperative Accelerated Partial Breast Irradiation (PAPBI) Trial.

H. Bartelink, E. Rutgers, J. Wesseling, 2020, International journal of radiation oncology, biology, physics.

[Intensity modulation in breast radiotherapy: development of an innovative field-in-field technique at Institut Gustave-Roussy].

J. Bourhis, D. Lefkopoulos, H. Marsiglia, 2011, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Radiomics: Definition and clinical development].

J. Colinge, C. Bourgier, M. Brengues, 2015, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Hypofractionated radiotherapy, a standard in breast cancer?].

C. Bourgier, O. Riou, C. Lemanski, 2013, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Early side effects of three-dimensional conformal external beam accelerated partial breast irradiation to a total dose of 40 Gy in one week (a phase II trial).

J. Bourhis, A. Taghian, M. Mathieu, 2011, International journal of radiation oncology, biology, physics.

Has partial breast irradiation by IORT or brachytherapy been prematurely introduced into the clinic?

H. Bartelink, C. Bourgier, P. Elkhuizen, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[Accelerated partial breast irradiation: bifractionated 40Gy in one week. A French pilot phase II study].

J. Bourhis, A. Taghian, M. Mathieu, 2010, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Effect of radiation dose on local control in breast cancer.

R. Arriagada, C. Bourgier, 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Induction of CTGF by TGF-beta1 in normal and radiation enteritis human smooth muscle cells: Smad/Rho balance and therapeutic perspectives.

J. Bourhis, C. Bourgier, J. Aigueperse, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[New external radiotherapy technologies for breast cancer].

C. Bourgier, P. Fenoglietto, D. Azria, 2014, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Successful mitigation of delayed intestinal radiation injury using pravastatin is not associated with acute injury improvement or tumor protection.

J. Bourhis, C. Bourgier, J. Aigueperse, 2007, International journal of radiation oncology, biology, physics.

Randomized phase 2 neoadjuvant trial evaluating anastrozole and fulvestrant efficacy for postmenopausal, estrogen receptor–positive, human epidermal growth factor receptor 2–negative breast cancer patients: Results of the UNICANCER CARMINA 02 French trial (UCBG 0609)

M. Mathieu, J. Lemonnier, V. Bécette, 2016, Cancer.

External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: A multicentric European experience.

M. Dieci, C. Thomssen, C. Bourgier, 2018, Breast.

Decision-making from multidisciplinary team meetings to the bedside: factors influencing the recruitment of breast cancer patients into clinical trials.

F. André, S. Delaloge, C. Mazouni, 2014, Breast.

Pravastatin Inhibits the Rho/CCN2/Extracellular Matrix Cascade in Human Fibrosis Explants and Improves Radiation-Induced Intestinal Fibrosis in Rats

J. Bourhis, M. Pocard, C. Bourgier, 2007, Clinical Cancer Research.

An unusual cause of upper gastrointestinal haemorrhage

J. Bourhis, F. Milliat, C. Bourgier, 2005, Gut.

Epac contributes to cardiac hypertrophy and amyloidosis induced by radiotherapy but not fibrosis.

E. Deutsch, C. Bourgier, S. Gourgou, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Intraoperative partial irradiation for highly selected patients with breast cancer: Results of the INTRAOBS prospective study.

P. Colombo, P. Rouanet, C. Bourgier, 2020, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Helical tomotherapy and volumetric modulated arc therapy: New therapeutic arms in the breast cancer radiotherapy.

C. Bourgier, O. Riou, A. Fourquet, 2016, World journal of radiology.

Mixed modality treatment planning of accelerated partial breast irradiation: to improve complex dosimetry cases

H. Marsiglia, C. Bourgier, R. Verstraet, 2011, Radiation oncology.

Partial breast irradiation: new standard for selected patients

C. Bourgier, D. Azria, 2010, The Lancet.

Clinical Correlations of Programmed Cell Death Ligand 1 Status in Liquid and Standard Biopsies in Breast Cancer.

F. Bidard, T. Maudelonde, V. D’Hondt, 2020, Clinical chemistry.

A phase I, dose-escalation study of the Eg5-inhibitor EMD 534085 in patients with advanced solid tumors or lymphoma

T. Baère, V. Lazar, J. Soria, 2013, Investigational New Drugs.

Ways to improve breast cancer patients' management and clinical outcome: The 2020 Assisi Think Tank Meeting.

L. Boersma, C. Coles, V. Valentini, 2022, Critical reviews in oncology/hematology.

Sequential research-related biopsies in phase I trials: acceptance, feasibility and safety.

T. de Baère, V. Lazar, J. Soria, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Partial versus whole breast irradiation: Side effects, patient satisfaction and costs.

C. Bourgier, I. Borget, S. Rivera, 2019, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Phase III randomized French multicentric study to evaluate the impact of a localized 16-Gy boost after conservative surgery and a 50-Gy whole-breast irradiation in breast ductal carcinoma in situ (the BONBIS trial).

P. Maingon, D. Cowen, C. Bourgier, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Concurrent or sequential letrozole with adjuvant breast radiotherapy: final results of the CO-HO-RT phase II randomized trial.

G. Romieu, M. Ozsahin, N. Crompton, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Efficacy, safety, and feasibility of volumetric modulated arc therapy for synchronous bilateral breast cancer management

C. Bourgier, C. Lemanski, S. Gourgou, 2022, Frontiers in Oncology.

Targeted therapy-induced radiation recall.

J. Soria, C. Robert, E. Deutsch, 2013, European journal of cancer.

Counterpoint: Conformal external beam for accelerated partial breast irradiation.

A. Taghian, C. Bourgier, 2009, Brachytherapy.

Point/Counterpoint: Brachytherapy or Conformal External Beam for Accelerated Partial Breast Irradiation? Counterpoint: Conformal external beam for accelerated partial breast irradiation

A. Taghian, C. Bourgier, 2009 .

Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology.

M. Dieci, C. Bourgier, P. Conte, 2018, The oncologist.

Abstract S1-6: TAMRAD: A GINECO Randomized Phase II Trial of Everolimus in Combination with Tamoxifen Versus Tamoxifen Alone in Patients (pts) with Hormone-Receptor Positive, HER2 Negative Metastatic Breast Cancer (MBC) with Prior Exposure to Aromatase Inhibitors (AI).

T. Delozier, D. Spaeth, P. Soulié, 2010 .

[Pharmacological modulation of late radio-induced side effects].

J. Bourhis, E. Deutsch, C. Bourgier, 2011, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

ESTRO consensus guideline for target volume delineation in the setting of postmastectomy radiation therapy after implant-based immediate reconstruction for early stage breast cancer

R. Jagsi, C. Coles, I. Mjaaland, 2019 .

Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohort

Tim E. Ward, J. Chang-Claude, P. Seibold, 2022, EBioMedicine.

[Radiosensitivity settings in breast cancer].

C. Bourgier, O. Riou, C. Lemanski, 2015, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

The Assisi Think Tank Meeting and Survey of post MAstectomy Radiation Therapy after breast reconstruction: The ATTM-SMART report.

G. Frezza, C. Coles, V. Valentini, 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Surgical clips assist in the visualization of the lumpectomy cavity in three-dimensional conformal accelerated partial-breast irradiation.

M. Mathieu, C. Balleyguier, A. Dunant, 2010, International journal of radiation oncology, biology, physics.

Overview of preoperative radiochemotherapy in breast cancer: past or future?

H. Marsiglia, C. Bourgier, Miguel Martín, 2011, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Effect of preoperative concomitant chemoradiotherapy in chemotherapy-refractory breast cancer on feasibility of curative surgery and pathologic tumor response.

C. Balleyguier, H. Marsiglia, S. Delaloge, 2010 .

Twenty-year results of alternating radiotherapy and chemotherapy in nonmetastatic inflammatory breast cancer.

R. Arriagada, M. Mathieu, A. Dunant, 2010 .

SHARE: a French multicenter phase III trial comparing accelerated partial irradiation versus standard or hypofractionated whole breast irradiation in breast cancer patients at low risk of local recurrence.

I. Dumas, J. Lemonnier, C. Bourgier, 2013, Clinical advances in hematology & oncology : H&O.

CANTO‐RT: Skin toxicities evaluation of a multicentre large prospective cohort of irradiated patients for early‐stage breast cancer

F. André, F. Paris, P. Cottu, 2022, International journal of cancer.

Higher toxicity with 42 Gy in 10 fractions as a total dose for 3D-conformal accelerated partial breast irradiation: results from a dose escalation phase II trial

I. Dumas, A. Taghian, M. Mathieu, 2012, Radiation oncology.

Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkers

G. Romieu, E. Crapez, P. Lamy, 2018, British Journal of Cancer.

Quality assurance program and early toxicities in the phase III BONBIS randomized trial evaluating the role of a localized radiation boost in ductal carcinoma in situ.

D. Cowen, C. Bourgier, U. Schick, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Phase II trial of 3D-conformal accelerated partial breast irradiation: lessons learned from patients and physicians' evaluation.

A. Taghian, H. Marsiglia, M. Spielmann, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A mixed-modality 3d-conformal accelerated partial breast irradiation technique using opposed mini-tangent photon fields and en face electrons to minimize the lung exposure to radiation: in regard to Jain et al. (Int J Radiat Oncol Biol Phys 2009;75:82-88).

A. Taghian, H. Marsiglia, C. Bourgier, 2010, International journal of radiation oncology, biology, physics.

Biphasic Temporal Relationship between Cancers and Systemic Sclerosis: A Clinical Series from Montpellier University Hospital and Review of the Literature

C. Bourgier, J. Morel, V. Rigau, 2020, Journal of clinical medicine.

Phase II randomized study of whole-brain radiation therapy with or without concurrent temozolomide for brain metastases from breast cancer.

J. Pierga, S. Gerber, C. Bourgier, 2015 .

Exclusive low-dose-rate brachytherapy in 279 patients with T2N0 mobile tongue carcinoma.

C. Fournier, B. Castelain, B. Coche-Déquéant, 2005, International journal of radiation oncology, biology, physics.

Preoperative radiotherapy in breast cancer patients: 32 years of follow-up.

R. Arriagada, A. Dunant, S. Delaloge, 2017, European journal of cancer.

Randomized phase II trial of everolimus in combination with tamoxifen in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer with prior exposure to aromatase inhibitors: a GINECO study.

I. Ray-Coquard, T. Bachelot, C. Bourgier, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcome in breast molecular subtypes according to nodal status and surgical procedures.

M. Mathieu, F. André, S. Delaloge, 2013, American journal of surgery.

Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome

M. Mathieu, T. Frebourg, H. Marsiglia, 2010, Radiation oncology.

[Partial breast irradiation].

C. Bourgier, O. Riou, C. Lemanski, 2014, Bulletin du cancer.

Fine‐needle aspiration cytopathology—An accurate diagnostic modality in mammary carcinoma with osteoclast‐like giant cells

M. Mathieu, C. Balleyguier, S. Delaloge, 2010, Cancer Cytopathology.

Clinical Benefit for Patients with Non-Small Cell Lung Cancer Enrolled in Phase I Trials

D. Planchard, J. Soria, C. Bourgier, 2013, Oncology Research and Treatment.

Rho/ROCK pathway as a molecular target for modulation of intestinal radiation-induced toxicity.

C. Bourgier, M. Vozenin-Brotons, V. Haydont, 2007, The British journal of radiology.

Radiotherapy for invasive breast cancer: guidelines for clinical practice from the French expert review board of Nice/Saint-Paul de Vence.

M. Héry, M. Namer, H. Marsiglia, 2011, Critical reviews in oncology/hematology.

Pure and mixed mucinous carcinoma of the breast: fine needle aspiration cytology findings and review of the literature

M. Mathieu, F. Andreiuolo, C. Balleyguier, 2013, Cytopathology : official journal of the British Society for Clinical Cytology.

Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkers

G. Romieu, E. Crapez, P. Lamy, 2018, British Journal of Cancer.

Phase II randomized study of whole-brain radiation therapy with or without concurrent temozolomide for brain metastases from breast cancer.

J. Pierga, S. Gerber, C. Bourgier, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Longitudinal analysis of health-related quality of life in cancer clinical trials: methods and interpretation of results

B. Chauffert, T. Conroy, C. Bascoul-Mollevi, 2020, Quality of Life Research.

Pharmacological strategies to spare normal tissues from radiation damage: useless or overlooked therapeutics?

C. Bourgier, A. Levy, M. Vozenin, 2012, Cancer and Metastasis Reviews.

Pravastatin Reverses Established Radiation-Induced Cutaneous and Subcutaneous Fibrosis in Patients With Head and Neck Cancer: Results of the Biology-Driven Phase 2 Clinical Trial Pravacur.

J. Bourhis, P. Taourel, N. Lassau, 2019, International journal of radiation oncology, biology, physics.

Influence of Nucleoshuttling of the ATM Protein in the Healthy Tissues Response to Radiation Therapy: Toward a Molecular Classification of Human Radiosensitivity.

J. Bourhis, D. Stoppa-Lyonnet, A. Puisieux, 2016, International journal of radiation oncology, biology, physics.

Decision of Adjuvant Systemic Treatment in HR+ HER2- Early Invasive Breast Cancer: Which Biomarkers Could Help?

V. D’Hondt, C. Bourgier, W. Jacot, 2019, Cancer management and research.

Multidisciplinary approach of early breast cancer: The biology applied to radiation oncology

M. Ozsahin, C. Bourgier, D. Azria, 2010, Radiation oncology.

Intriguing Relationships Between Cancer and Systemic Sclerosis: Role of the Immune System and Other Contributors

D. Noël, C. Bourgier, J. Morel, 2019, Front. Immunol..

Management of the Axilla in the Era of Breast Cancer Heterogeneity

C. Bourgier, C. Lemanski, P. Fenoglietto, 2018, Front. Oncol..

ESTRO ACROP consensus guideline for target volume delineation in the setting of postmastectomy radiation therapy after implant-based immediate reconstruction for early stage breast cancer.

Boon Chua, Meritxell Arenas, Reshma Jagsi, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Effect of preoperative rescue concomitant FUN/XUN-based chemo-radiotherapy for neoadjuvant chemotherapy-refractory breast cancer.

C. Balleyguier, H. Marsiglia, S. Delaloge, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[What type of hypofractionated radiotherapy of primary tumours in palliative care?].

C. Bourgier, D. Azria, P. Boisselier, 2015, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Early breast cancer without axillary lymph node involvement].

H. Marsiglia, S. Kanoun, C. Bourgier, 2010, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Breast cancer with axillary lymph node involvement].

H. Marsiglia, C. Bourgier, S. Heymann, 2010, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Breast radiotherapy as part of loco-regional treatments in stage IV breast cancer patients with oligometastatic disease.

R. Arriagada, M. Mathieu, C. Balleyguier, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

CANTO-RT: One of the Largest Prospective Multicenter Cohort of Early Breast Cancer Patients Treated with Radiotherapy including Full DICOM RT Data

S. Everhard, C. Bourgier, D. Pasquier, 2023, Cancers.

Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity

J. Chang-Claude, A. Dunning, R. Stock, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

XRCC1 Polymorphism Associated With Late Toxicity After Radiation Therapy in Breast Cancer Patients.

J. Chang-Claude, J. Debus, A. Dunning, 2015, International journal of radiation oncology, biology, physics.

Genomic classifications and radiotherapy for breast cancer.

C. Bourgier, C. Rossier, P. Ezra, 2013, European journal of pharmacology.

Higher Anti-Tumor Efficacy of the Dual HER3-EGFR Antibody MEHD7945a Combined with Ionizing Irradiation in Cervical Cancer Cells.

C. Bourgier, M. Jarlier, A. Pèlegrin, 2020, International journal of radiation oncology, biology, physics.

Performance of a Knowledge-Based Model for Optimization of Volumetric Modulated Arc Therapy Plans for Single and Bilateral Breast Irradiation

Pietro Mancosu, Luca Cozzi, Giorgia Nicolini, 2015, PloS one.

Stereotactic MR-Guided Radiotherapy for Liver Metastases: First Results of the Montpellier Prospective Registry Study

M. Ychou, E. Assenat, T. Mazard, 2023, Journal of clinical medicine.

Impact of radiation therapy on fatigue at 1 year in breast cancer survivors in the prospective multicentre CANcer TOxicity cohort.

F. Paris, A. Di Meglio, S. Everhard, 2022, European journal of cancer.

The 2018 assisi think tank meeting on breast cancer: International expert panel white paper.

L. Boersma, C. Coles, V. Valentini, 2020, Critical reviews in oncology/hematology.

Magnetic resonance imaging in breast cancer management in the context of neo-adjuvant chemotherapy.

P. Crochet, P. Rouanet, P. Taourel, 2018, Critical reviews in oncology/hematology.

New perspectives in radiation oncology: Young radiation oncologist point of view and challenges.

H. Marsiglia, C. Bourgier, Michelle M. Kim, 2012, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

Hypofractionated helical tomotherapy using 2.5–2.6 Gy daily fractions for localized prostate cancer

H. Marsiglia, C. Bourgier, A. Sánchez-Reyes, 2013, Clinical and Translational Oncology.

Stereotactic ablative radiotherapy delivered by image-guided helical tomotherapy for extracranial oligometastases

H. Marsiglia, C. Bourgier, A. Sánchez-Reyes, 2013, Clinical and Translational Oncology.

Adjuvant radiotherapy in the management of axillary node negative invasive breast cancer: a qualitative systematic review.

M. Bollet, C. Bourgier, C. Hennequin, 2013, Critical reviews in oncology/hematology.

The 2016 Assisi Think Tank Meeting on breast cancer: white paper

G. Frezza, C. Coles, V. Valentini, 2016, Breast Cancer Research and Treatment.

Exclusive alternating chemotherapy and radiotherapy in nonmetastatic inflammatory breast cancer: 20 years of follow-up.

R. Arriagada, M. Mathieu, A. Dunant, 2012, International journal of radiation oncology, biology, physics.

First results of the preoperative accelerated partial breast irradiation (PAPBI) trial.

Harry Bartelink, Corine van Vliet-Vroegindeweij, M. J. van de Vijver, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Different meaning of the mean heart dose between 3D-CRT and IMRT for breast cancer radiotherapy

C. Bourgier, C. Lemanski, S. Gourgou, 2023, Frontiers in Oncology.

Adjuvant breast radiotherapy in patients aged 65 and over: Not a binary decision

C. Bourgier, C. Lemanski, D. Azria, 2023, Cancer/Radiothérapie.

Characteristics, treatment, and outcome of breast cancers diagnosed in BRCA1 and BRCA2 gene mutation carriers in intensive screening programs including magnetic resonance imaging.

M. Mathieu, F. André, C. Balleyguier, 2010, Clinical breast cancer.

[Hypofractionated stereotactic radiotherapy of bone metastases].

C. Bourgier, M. Mahé, S. Supiot, 2014, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Loco‐regional Control After Neo‐adjuvant Chemotherapy and Conservative Treatment for Locally Advanced Breast Cancer Patients

C. Balleyguier, P. Vielh, C. Bourgier, 2014, The breast journal.

Robustness of Breast Margins with Volumetric Modulated Arc Therapy without a Six-Degrees-of-Freedom Couch: A Dosimetric Evaluation

C. Bourgier, P. Fenoglietto, D. Azria, 2023, Journal of clinical medicine.

The Assisi Think Tank Meeting Survey of post-mastectomy radiation therapy in ductal carcinoma in situ: Suggestions for routine practice.

C. Coles, V. Valentini, F. Marazzi, 2019, Critical reviews in oncology/hematology.

The 2022 Assisi Think Tank Meeting: White paper on optimising radiation therapy for breast cancer.

V. Valentini, F. Marazzi, V. Masiello, 2023, Critical reviews in oncology/hematology.

[Reirradiation of normal tissues: preclinical radiobiological data].

C. Bourgier, M. Vozenin, E. Deutsch, 2010, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

BRCA1 germ-line mutation: Predictive of sensitivity to anthracyclin alkylating agents regimens but not to taxanes?

F. André, F. Bidard, M. Spielmann, 2008 .

Pharmacological strategies to spare normal tissues from radiation damage: useless or overlooked therapeutics?

C. Bourgier, A. Levy, M. Vozenin, 2012, Cancer and Metastasis Reviews.

Abstract OT1-2-02: SHARE. A French multiceter phase III trial comparing accelerated partial irradiation (APBI) versus standard or hypofractionated whole breast irradiation in low risk of local recurrence breast cancer

I. Dumas, C. Bourgier, A. Kramar, 2012 .

Early onset breast cancer: differences in risk factors, tumor phenotype, and genotype between North African and South European women

D. Khayat, M. Picot, P. Pujol, 2017, Breast Cancer Research and Treatment.

Personalizing Breast Cancer Irradiation Using Biology: From Bench to the Accelerator

C. Bourgier, M. Brengues, S. Gourgou, 2018, Front. Oncol..

[Ductal carcinoma in situ: role of the boost].

I. Barillot, P. Maingon, A. Monnier, 2008, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Feasibility of accelerated partial breast irradiation with volumetric-modulated arc therapy in elderly and frail patients

C. Bourgier, O. Riou, C. Lemanski, 2015, Radiation oncology.

[Prevalence of elevated serum CA 15-3 at time of metastatic relapse of breast cancer and correlation with hormone receptor status].

F. André, M. Spielmann, S. Delaloge, 2009, Bulletin du cancer.

Quantitative proteomic analysis reveals AK2 as potential biomarker for late normal tissue radiotoxicity

J. Solassol, A. Mangé, M. Ozsahin, 2019, Radiation oncology.

Three-field electron/minitangent photon technique offer dosimetric advantages to a multifield, photon-only technique for accelerated partial breast irradiation if well implemented.

A. Taghian, H. Marsiglia, C. Bourgier, 2011, American journal of clinical oncology.

Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer.

J. Chang-Claude, C. Luccarini, P. Seibold, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Total recall of radiotherapy with mTOR inhibitors: a novel and potentially frequent side-effect?

J. Soria, C. Bourgier, C. Moldovan, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[Partial breast irradiation].

C. Bourgier, O. Riou, C. Lemanski, 2014, Bulletin du cancer.

Decision of Adjuvant Systemic Treatment in HR+ HER2- Early Invasive Breast Cancer: Which Biomarkers Could Help?

C. Bourgier, W. Jacot, S. Guiu, 2019 .

[An updated synthesis of the international recommendations about the use of non-pharmacological interventions in the treatment of fatigue].

F. Alla, S. Dauchy, C. Charles, 2021, Bulletin du cancer.

I. Ray-Coquard, T. Bachelot, C. Bourgier, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Early breast cancer without axillary lymph node involvement].

H. Marsiglia, S. Kanoun, C. Bourgier, 2010, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

PRAVASTATIN REVERSES ESTABLISHED RADIATION-INDUCED CUTANEOUS AND SUBCUTANEOUS FIBROSIS IN PATIENTS WITH HEAD AND NECK CANCER: RESULTS OF THE BIOLOGY-DRIVEN PHASE II CLINICAL TRIAL

C. Bourgier, A. Aupérin, B. Petit, 2020 .

[Treatment of oligometastatic or oligoprogression cancer].

C. Bourgier, O. Riou, P. Fenoglietto, 2019, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Breast radiotherapy as part of loco-regional treatments in stage IV breast cancer patients with oligometastatic disease.

R. Arriagada, M. Mathieu, C. Balleyguier, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Preoperative radiotherapy in breast cancer patients: 32 years of follow-up.

A. Dunant, S. Delaloge, C. Mazouni, 2017, European journal of cancer.

External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: A multicentric European experience.

M. Dieci, C. Thomssen, C. Bourgier, 2018, Breast.

Pure and mixed mucinous carcinoma of the breast: fine needle aspiration cytology findings and review of the literature

F. Andreiuolo, C. Balleyguier, S. Delaloge, 2013, Cytopathology : official journal of the British Society for Clinical Cytology.

[Breast cancer radiation therapy: Current questions in 2023].

M. Bollet, A. Arnaud, C. Bourgier, 2023, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Partial breast irradiation].

C. Bourgier, O. Riou, C. Lemanski, 2014, Bulletin du cancer.

Evaluation of Ethos intelligent optimization engine for left locally advanced breast cancer

C. Bourgier, P. Fenoglietto, A. Morel, 2024, Frontiers in Oncology.